These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 35380707)

  • 41. Healthcare Economics of a Coronavirus Disease 2019 Pop-Up Vaccination Center.
    Caruana DL; Dunn RJ; Dhuper SK; Szema AM
    Yale J Biol Med; 2022 Jun; 95(2):191-197. PubMed ID: 35782468
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical evaluation of proteinuric glomerulonephritis with special reference to lipoid nephrosis].
    CHIESURA P
    Minerva Nefrol; 1956; 3(1):1-14. PubMed ID: 13334134
    [No Abstract]   [Full Text] [Related]  

  • 43. Mucolytic enzyme systems. XI. Hyaluronidase inhibitor and serum mucoproteins in patients with lipoid nephrosis and acute glomerulonephritis.
    KELLEY VC; GOOD RA; GLICK D; OCHS MJ
    J Clin Invest; 1950 Nov; 29(11):1500-4. PubMed ID: 14794778
    [No Abstract]   [Full Text] [Related]  

  • 44. Acquired Angioedema Acute Attack After Administration of the Moderna COVID-19 (mRNA-1273) Vaccine.
    Graziani A; Savrie C; Sama MG
    Arch Bronconeumol; 2023 Mar; 59(3):165-166. PubMed ID: 36243635
    [No Abstract]   [Full Text] [Related]  

  • 45. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
    Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P
    Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine.
    Baldolli A; Fournier A; Verdon R; Michon J
    Clin Microbiol Infect; 2022 Jun; 28(6):885.e1-885.e5. PubMed ID: 35182759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffuse glomerulonephritis; suggested classification with special reference to so-called lipoid nephrosis.
    WARTHEN RO; SHERBURNE JC
    Clin Proc Child Hosp Dist Columbia; 1948 Mar; 4(4):75-83. PubMed ID: 18859429
    [No Abstract]   [Full Text] [Related]  

  • 48. [Investigation of Foreign Particles in Moderna COVID-19 Vaccine].
    Shibata H; Nomura Y; Kawakami T; Yamamoto E; Ando D; Uchiyama N; Tokumoto H; Koide T; Sakoda H; Yoshida H; Abe Y; Hakamatsuka T; Ikarashi Y; Haishima Y; Ishii-Watabe A; Izutsu KI; Honma M; Goda Y
    Yakugaku Zasshi; 2022; 142(8):867-874. PubMed ID: 35908947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.
    Sheng WH; Chang SY; Lin PH; Hsieh MJ; Chang HH; Cheng CY; Yang HC; Pan CF; Ieong SM; Chao TL; Chen JP; Cheng SH; Chang SC
    J Formos Med Assoc; 2022 Apr; 121(4):766-777. PubMed ID: 35305895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study of humoral and cellular immunity in vaccinated with mRNA-1273.
    Gutiérrez-Bautista JF; López-Nevot MÁ; Gómez-Vicente E; Quesada T; Marín EM; Rodríguez A; Rodríguez AI; Rodríguez-Granger J; Cobo F; Sampedro A
    APMIS; 2022 May; 130(5):261-269. PubMed ID: 35196403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anatomo-clinical notes on lipoid nephrosis and nephropathies with renal lipoidosis].
    MARTIN JF; FEROLDI J
    Toulouse Med; 1952 Dec; 53(11):899-906. PubMed ID: 13049435
    [No Abstract]   [Full Text] [Related]  

  • 52. Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis.
    Yau K; Chan CT; Abe KT; Jiang Y; Atiquzzaman M; Mullin SI; Shadowitz E; Liu L; Kostadinovic E; Sukovic T; Gonzalez A; McGrath-Chong ME; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Levin A; Blake PG; Colwill K; Gingras AC; Hladunewich MA
    CMAJ; 2022 Feb; 194(8):E297-E305. PubMed ID: 35115375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is a single dose of mRNA vaccine sufficient for COVID-19 survivors?
    Malek AE; Dagher H; Hachem R; Chaftari AM; Raad II
    J Med Virol; 2021 Jul; 93(7):4083-4084. PubMed ID: 33666244
    [No Abstract]   [Full Text] [Related]  

  • 54. Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges.
    Sagili Anthony DP; Sivakumar K; Venugopal P; Sriram DK; George M
    Clin Drug Investig; 2021 Jun; 41(6):499-509. PubMed ID: 33754328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody Responses after Two Doses of COVID-19 mRNA Vaccine in Dialysis and Kidney Transplantation Patients Recovered from SARS-CoV-2 Infection.
    Cappuccilli M; Semprini S; Fabbri E; Fantini M; Bruno PF; Spazzoli A; Righini M; Flachi M; La Manna G; Sambri V; Mosconi G
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888612
    [No Abstract]   [Full Text] [Related]  

  • 56. Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers.
    Moncunill G; Aguilar R; Ribes M; Ortega N; Rubio R; Salmerón G; Molina MJ; Vidal M; Barrios D; Mitchell RA; Jiménez A; Castellana C; Hernández-Luis P; Rodó P; Méndez S; Llupià A; Puyol L; Rodrigo Melero N; Carolis C; Mayor A; Izquierdo L; Varela P; Trilla A; Vilella A; Barroso S; Angulo A; Engel P; Tortajada M; García-Basteiro AL; Dobaño C
    EBioMedicine; 2022 Jan; 75():103805. PubMed ID: 35032961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine.
    Islam N; Sheils NE; Jarvis MS; Cohen K
    Nat Commun; 2022 May; 13(1):2377. PubMed ID: 35501319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
    Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y
    Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study.
    Bruxvoort KJ; Sy LS; Qian L; Ackerson BK; Luo Y; Lee GS; Tian Y; Florea A; Aragones M; Tubert JE; Takhar HS; Ku JH; Paila YD; Talarico CA; Tseng HF
    BMJ; 2021 Dec; 375():e068848. PubMed ID: 34911691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disparity in Public Perception of Pfizer and Moderna COVID-19 Vaccines on TikTok.
    Baumel NM; Spatharakis JK; Baumel LD; Sellas EI
    J Adolesc Health; 2022 Mar; 70(3):514. PubMed ID: 35183320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.